Contact

Payer

Pharma

Provider

Formulary guidance and transparency from P&T to point of care

Trends That Matter for Acne Treatment

Posted by Matt Breese on Nov 9, 2017

The global acne treatment market is growing, and experts predict it will continue to grow through 2021. According to a report published by CISION, this growth can be attributed to several factors including rising disposable income, unhealthy eating habits, and increasing awareness about acne treatment options. 

However, CISION also outlined some challenges in the market including, "The entry of generic drugs, safety issue regarding products and increasing acceptance of anti-acne treatments that hinder the growth of the market."

Read More

Topics: Industry Trends

Perspectives on Real-World Data

Posted by Matt Breese on Nov 7, 2017

The pharmaceutical industry has seen an explosion in the availability of real-world data in recent years. In the past, pharma companies mainly relied on data from clinical trials. Today, real-world data provides new insights and opportunities to assess a broader population.

This information is increasingly influencing healthcare decision-makers. However, data scientists must have the skills to sort through unstructured health data, analyze it, understand the big picture, and portray the data visually. 

Read More

Topics: Industry Trends, Data & Analytics

Trends That Matter for Pharma Manufacturing

Posted by Matt Breese on Nov 2, 2017

Cutting-edge manufacturers know the importance of embracing new technologies. Pharma manufacturers are beginning to invest more in robotics and analytics to improve the efficiency at their plants. 

Specifically, Sanofi, pharma company headquartered in France, is making substantial investments in the area of collaborative robotics. Sanofi's biologics plant in Geel, Belgium uses digital tools to reduce opportunities for errors in the manufacturing process.  

Read More

Topics: Industry Trends

Perspectives on Specialty Pharmacies

Posted by Matt Breese on Oct 31, 2017

The promising outlook on specialty drug growth and profitability is attracting new competitors to the market. According to Matthew Panos, Program Manager of Retail Specialty Solutions at McKesson, “Patients who take specialty medications typically have three to 11 additional prescriptions, making them valuable patients."

Parties that dispense specialty drugs include PBMs, health plans, chain stores, pharma wholesalers, hospital systems, physician practices and independent pharmacies.  

Read More

Topics: Specialty, Industry Trends

Perspectives on Payer Trends

Posted by Matt Breese on Oct 24, 2017

The healthcare environment is always changingToday, payers are facing high administrative costs. Increasing admin costs and pressing healthcare reforms are motivating payers to improve their efficiency. 

For example, "To reduce administrative costs and meet regulatory mandates, payers are implementing more efficient payment delivery methods," according to InstaMed.

Read More

Topics: Industry Trends, Payer

Perspectives on Biopharmaceutical R&D

Posted by Matt Breese on Oct 17, 2017

Advancements in science and technology are leading to increased innovation in the biopharmaceutical industry. A promising pipeline reveals the industry's strong commitments to discovery and innovation. 

Biopharmaceutical companies consistently invest in R&D. In fact, more than 500 new drugs have been approved by the FDA since the year 2000, according to PhRMA.

Read More

Topics: Industry Trends

Formulary Coverage Changes for 2018 Medicare

Posted by Matt Breese on Oct 8, 2017

Over the past couple of years, pharma has seen major shifts in how Medicare sponsors have changed their coverage methodologies. In addition, overall coverage of trending disease areas for Medicare formularies has shifted.

For instance, we've seen major shifts for asthma and COPD treatments within Medicare Part D - with a significant increase in the percentage of lives either not covered or restricted by PAs and step edits.

Read More

Topics: Specialty, Industry Trends, Market Access

Trends That Matter for STEM Opportunities

Posted by Matt Breese on Oct 5, 2017

In our weekly Trends that Matter series, we provide infographics, articles and recent news from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is STEM opportunities. Since the pharma industry relies heavily on technology and innovation for economic development, a skilled STEM workforce is essential.

There are many opportunities to build a prosperous career in the STEM fields. According to a report by the U.S. Bureau of Labor Statistics, the national average wage for STEM occupations is nearly double the national average wage for the non-STEM professions.

Read More

Topics: Industry Trends

Trends That Matter for Customer Centricity in Pharma

Posted by Matt Breese on Sep 28, 2017

In our weekly Trends that Matter series, we provide infographics, articles and recent news from healthcare influencers to highlight general trends affecting the pharmaceutical industry. This week's featured topic is how the pharma industry can shift away from brand centricity and adopt a more customer-centric approach.

The pharmaceutical industry has been significantly slower to adopt a customer-centric approach than other industries. In the case of pharma, HCPs are considered one group of "customers." According to Kevin Troyanos' recent piece in Pharma Exec MagazineHCPs today expect more personalized messaging and less generic sales tactics. 

Read More

Topics: Industry Trends, Branding & Marketing

Perspectives on Top Therapy Areas

Posted by Matt Breese on Sep 26, 2017

Many new pharmaceutical treatment options have been introduced to the market this year. Areas such as oncology, anti-rheumatics, and anti-virals are driving growth in the industry. However, oncology remains the top therapeutic area with a worldwide market share of 11.7%. 

The industry has seen momentum from investment in the development of new drugs in these key therapeutic areas. This innovation is also leading to increased prescription drug sales. According to the QuintilesIMS National Prescription Audit database, the total retail sales for prescription drugs filled at pharmacies in the U.S. totaled $379,247,789,544 in the 2016 calendar year.

Read More

Topics: Industry Trends